Premium
Cannabidiol affects circadian clock core complex and its regulation in microglia cells
Author(s) -
Lafaye Geneviève,
Desterke Christophe,
Marulaz Laurent,
Benyamina Amine
Publication year - 2019
Publication title -
addiction biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.445
H-Index - 78
eISSN - 1369-1600
pISSN - 1355-6215
DOI - 10.1111/adb.12660
Subject(s) - circadian rhythm , per1 , cannabidiol , microglia , circadian clock , per2 , suprachiasmatic nucleus , neuroscience , biology , medicine , clock , pharmacology , endocrinology , cannabis , psychiatry , inflammation
Cannabis is often used by consumers for sleep disorders. Studies show that circadian rhythm could be affected by a misuse of cannabis. Recent research has connected the role of microglial cells with psychiatric disorders such as substance abuse. The aim was to show the effect of two major components of cannabis on circadian genes regulation in microglial cells. In BV‐2 microglial cells, cannabidiol (CBD) induces a deregulation of circadian genes with ( P ‐value = 0.039) or without ( P ‐value = 0.0015) lipopolisaccharides stimulation. CBD up regulated Arntl ( P = 9.72E‐5) and down regulated Clock ( P = 0.0034) in BV‐2 cells. Temporal expression of Arntl (light and dark P = 0.0054) and Clock (light and dark P = 0.047) was confirmed to have 24 hours light and dark rhythmic regulation in dissected suprachiasmatic nucleus as well as of Cb1 cannabinoid receptor (light and dark P = 0.019). In BV‐2 microglia cells, CBD also up regulated CRY2 ( P = 0.0473) and PER1 ( P = 0.0131). Other nuclear molecules show a deregulation of circadian rhythm in microglial cells by CBD, such as RORA, RevErbα, RORB, CREBBP, AFT4, AFT5 and NFIL3. Our study suggests that circadian rhythm in microglial cells is deregulated by CBD but not by THC. It is consistent with clinical observations of the use of therapeutic cannabis to treat insomnia.